Avidity Biosciences Total Liabilities 2019-2024 | RNA

Avidity Biosciences total liabilities for the quarter ending September 30, 2024 were $0.137B, a 146.68% increase year-over-year.

  • Avidity Biosciences total liabilities for 2023 were $0.128B, a 110.44% increase from 2022.
  • Avidity Biosciences total liabilities for 2022 were $0.061B, a 31.58% increase from 2021.
  • Avidity Biosciences total liabilities for 2021 were $0.046B, a 66.76% increase from 2020.

Avidity Biosciences Total Liabilities 2019-2024 | RNA

  • Avidity Biosciences total liabilities for 2023 were $0.128B, a 110.44% increase from 2022.
  • Avidity Biosciences total liabilities for 2022 were $0.061B, a 31.58% increase from 2021.
  • Avidity Biosciences total liabilities for 2021 were $0.046B, a 66.76% increase from 2020.